Ion Bio Med-Icare Profile
Key Indicators
- Authorised Capital ₹ 14.00 Cr
as on 27-12-2024
- Paid Up Capital ₹ 11.60 Cr
as on 27-12-2024
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -31.76%
(FY 2021)
- Profit -144.79%
(FY 2021)
- Ebitda -28.62%
(FY 2021)
- Net Worth -0.18%
(FY 2021)
- Total Assets -0.12%
(FY 2021)
About Ion Bio Med-Icare
The Corporate was formerly known as Usha Drager Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.00 Cr and a paid-up capital of Rs 11.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhisham Wadhwa, Rajiv Kumar, and Anil Gupta serve as directors at the Company.
- CIN/LLPIN
U93000DL1988PTC033443
- Company No.
033443
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ion Bio Med-Icare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Kumar  | Director | 17-Aug-2024 | Current |
| Bhisham Wadhwa | Director | 26-Sep-2009 | Current |
| Anil Gupta | Additional Director | 05-Sep-2023 | Current |
Financial Performance of Ion Bio Med-Icare.
Ion Bio Med-Icare Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 31.76% decrease. The company also saw a substantial fall in profitability, with a 144.79% decrease in profit. The company's net worth dipped by a decrease of 0.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ion Bio Med-Icare?
In 2021, Ion Bio Med-Icare had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Iilm Publishing Private LimitedActive 15 years 2 monthsRajiv Kumar and Anil Gupta are mutual person
Rkkr Biotechnology Private LimitedActive 19 years 11 monthsRajiv Kumar and Anil Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ion Bio Med-Icare?
Unlock and access historical data on people associated with Ion Bio Med-Icare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ion Bio Med-Icare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ion Bio Med-Icare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
